Physician

David B Vasily, MD

According to 2025 Medicare claims, David Vasily, MD (NPI: 1154327468) practices dermatology in the Allentown-Bethlehem-Easton, PA-NJ market, with the plurality of this provider's patient population coming from Northampton, PA. This provider's primary affiliated billing organization is LEHIGH VALLEY DERMATOLOGY ASSOC LTD (NPI: 1316986763; TIN: 232457332) and primary practice location at 18017-8617.

Vasily's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,107 traditional Medicare patients, billed 53,555 HCPCS/CPT codes, and received $1,111,673 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 36 prescription claims across 17 beneficiaries totaling $4,318 in drug costs. Open Payments data shows 40 records totaling $842. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $104,255 to $1,111,673. In contrast, Part D prescription costs have declined steadily, from $213,360 to $4,318. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$556K$1.1M2015 Medicare payment: $104,255 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $107,317 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $101,831 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $89,261 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $526,241 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $505,414 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $933,398 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,093,797 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,089,767 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,111,673 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154922,266$104,255
20165362,371$107,317
20175022,477$101,831
20184712,191$89,261
20196377,079$526,241
20205646,086$505,414
202196416,383$933,398
20221,81147,521$1,093,797
20231,87251,560$1,089,767
20242,10753,555$1,111,673

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$108K$216K2015 Drug cost: $213,360 (USD; Tot_Drug_Cst)2016 Drug cost: $188,503 (USD; Tot_Drug_Cst)2017 Drug cost: $202,081 (USD; Tot_Drug_Cst)2018 Drug cost: $142,586 (USD; Tot_Drug_Cst)2019 Drug cost: $216,355 (USD; Tot_Drug_Cst)2020 Drug cost: $136,590 (USD; Tot_Drug_Cst)2021 Drug cost: $4,991 (USD; Tot_Drug_Cst)2022 Drug cost: $1,663 (USD; Tot_Drug_Cst)2023 Drug cost: $1,510 (USD; Tot_Drug_Cst)2024 Drug cost: $4,318 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015157423$213,360
2016158360$188,503
2017149329$202,081
2018156353$142,586
2019164466$216,355
202082206$136,590
20212450$4,991
20222343$1,663
20232247$1,510
20241736$4,318

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth527587$63
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,4432,303$59
17000Destruction of precancer skin growth, 1 growth626829$39
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more465599$36
17003Destruction of precancer skin growth, 2-14 growths3711,498$4

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.40$842Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David B. Vasily, MD?

Tedicare shows public-source Medicare data for David B. Vasily, MD (NPI 1154327468), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David B. Vasily, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David B. Vasily, MD?

David B. Vasily, MD is linked to LEHIGH VALLEY DERMATOLOGY ASSOC LTD (billing NPI 1316986763) in the available physician profile data.

Does David B. Vasily, MD have Open Payments data?

David B. Vasily, MD has 40 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.